GP Petroleums board approves ₹130 crore fundraise via NCDs and OCDs
- GP Petroleums board approved a fundraise of up to ₹130 crore via NCDs and OCDs
- Instruments issued to RevX Special Credit Opportunities Fund II on private placement basis
- Structure includes ₹30 crore NCDs (36 months) and ₹100 crore OCDs (18 months)
- Coupon rate set at 13% p.a., compounded monthly, with additional 1.5% on allotment
- OCD conversion price fixed at ₹62.09 per share, subject to shareholder approval

*this image is generated using AI for illustrative purposes only.
GP Petroleums has announced Board approval for a proposed fundraise of up to ₹130 crore through the issue of Non-Convertible Debentures (NCDs) and Optionally Convertible Debentures (OCDs). The instruments will be issued on a private placement basis to RevX Special Credit Opportunities Fund II.
The fundraising is structured in two components: up to 300 NCDs aggregating up to ₹30 crore with a tenor of 36 months, and up to 1,000 OCDs aggregating up to ₹100 crore with a tenor of 18 months. Both instruments carry a face value of ₹10 lakh each. The company plans to utilize the proceeds to fund ongoing business expansion and fulfill working capital requirements.
Fundraising structure and terms
The OCD tranche, previously detailed in a separate shareholder notice, carries a conversion price of ₹62.09 per equity share. The NCDs are fixed-income debt securities, while the OCDs offer the investor an option to convert into equity. Both instruments bear a coupon rate of 13% p.a., compounded monthly and paid quarterly. Additionally, the company will pay an additional coupon of 1.5% on the deemed date of allotment.
| Parameter | Details |
|---|---|
| Total Fundraise Amount | Up to ₹130 crore |
| NCD Component | Up to ₹30 crore (300 units) |
| OCD Component | Up to ₹100 crore (1,000 units) |
| Investor | RevX Special Credit Opportunities Fund II |
| Coupon Rate | 13% p.a. + 1.5% additional on allotment |
| NCD Tenor | 36 months |
| OCD Tenor | 18 months |
| Conversion Price | ₹62.09 per share (OCDs only) |
The OCD issue is subject to necessary statutory approvals, including shareholders' consent through the upcoming postal ballot. Equity shares arising from the conversion of OCDs are proposed to be listed on BSE and NSE. Mr. Dilip Vaswani, Non-Executive Director, stated that the financing provides financial agility to accelerate growth plans, both organic and inorganic, reflecting confidence in the company's strategic vision.
Shareholder approval process
Separately, GP Petroleums has dispatched a postal ballot notice seeking shareholder approval specifically for the ₹100 crore OCD tranche. The remote e-voting period for these resolutions commenced on October 2, 2026, and will conclude on October 31, 2026. The proposal also includes the appointment of two new independent directors:
- Ms. Priyanka Sinha: Appointed as Additional Director on August 12, 2026. She is a strategic consultant and General Counsel with expertise in legal strategy and corporate governance. Her tenure is proposed until August 11, 2028.
- Mr. Rahul Arun Shetty: Appointed as Additional Director on September 21, 2026. He is a UK-based investment professional and Founder & Director of Optimus Investments, with over 20 years of experience in investment banking and real estate. His tenure is proposed until September 20, 2028.
What the Numbers Show
The combined capital raise from RevX Special Credit Opportunities Fund II totals ₹130 crore under this specific board approval, comprising the ₹30 crore NCDs and ₹100 crore OCDs. The high coupon rate of 13% p.a., coupled with the additional 1.5% payment on allotment, indicates a significant cost of capital. This reliance on structured debt financing rather than traditional bank loans suggests the company is prioritizing flexible capital access for its expansion plans despite the higher interest burden.
Historical Stock Returns for GP Petroleums
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.79% | -5.31% | -8.24% | +76.58% | +46.38% | +8.69% |
How will the 13% coupon rate impact GP Petroleums' interest coverage ratio and overall profitability in the next two fiscal years?
What specific organic and inorganic expansion projects are prioritized for the ₹130 crore proceeds, and what are their expected ROI timelines?
Given the ₹62.09 conversion price, how does this valuation compare to current market levels, and what dilution impact is projected for existing shareholders upon OCD conversion?


































